Avenue Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Robert Davidow(2.9%)
Avenue Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(8.0%)
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
Avenue Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Avenue Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Robert Davidow(9.89%)
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Davidow Robert L
Avenue Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Robert Davidow(14.5%)
Avenue Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Davidow Robert L
Avenue Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(12.1%)
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROSENWALD LINDSAY A MD
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jin David
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROSENWALD LINDSAY A MD
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KRANZLER JAY D
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Oltmans Curtis Gale
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Herskowitz Neil
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer MacLean Alexandra
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
No Data